Baxter International BAX Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxCreditsResearch.
The official record: Baxter International’s 10-K, filed February 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Baxter International's effective income tax rate reconciliation, tax credit, research, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Baxter International's effective income tax rate reconciliation, tax credit, research, amount?
- Baxter International (BAX) reported effective income tax rate reconciliation, tax credit, research, amount of $4.5M in Q4 2025.
- How has Baxter International's effective income tax rate reconciliation, tax credit, research, amount changed year-over-year?
- Baxter International's effective income tax rate reconciliation, tax credit, research, amount decreased by 5.3% year-over-year, from $4.75M to $4.5M.
- What is the long-term trend for Baxter International's effective income tax rate reconciliation, tax credit, research, amount?
- Over 4 years (2021 to 2025), Baxter International's effective income tax rate reconciliation, tax credit, research, amount has grown at a 45.6% compound annual growth rate (CAGR), from $4M to $18M.
- What does effective income tax rate reconciliation, tax credit, research, amount mean?
- The dollar amount of tax credits earned from research and development investments.
- How do you interpret effective income tax rate reconciliation, tax credit, research, amount?
- Higher values indicate robust R&D investment and successful capture of innovation-related tax incentives.
- How does effective income tax rate reconciliation, tax credit, research, amount compare across companies?
- Common in R&D-intensive industries like medical devices, pharmaceuticals, and technology.